Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai
Patent
1998-04-17
1999-11-16
Crane, L. Eric
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heavy metal containing doai
514 8, 514 54, 514184, 556136, 556137, 536101, A61K 3128
Patent
active
059859164
ABSTRACT:
A polymer-platinum compound for use in tumor treatment is described. The compound is composed of a biodegradable diamido-diamine polymer linked to a platinum species. The platinum species is released from the polymer to yield a platinum species having anti-tumor activity.
REFERENCES:
patent: 4062831 (1977-12-01), Kopecek et al.
patent: 4097470 (1978-06-01), Drobnik et al.
patent: 5037883 (1991-08-01), Kopecek et al.
patent: 5362831 (1994-11-01), Mongelli et al.
patent: 5420105 (1995-05-01), Gustavson et al.
patent: 5473055 (1995-12-01), Mongelli et al.
patent: 5547667 (1996-08-01), Angelucci et al.
patent: 5569720 (1996-10-01), Mongelli et al.
patent: 5629384 (1997-05-01), Veronese et al.
patent: 5631322 (1997-05-01), Veronese et al.
patent: 5631336 (1997-05-01), Ferruti et al.
Bogdanov, A.A., et al., "An Adduct of cis-Diamminedichloroplatinum(II) and poly(ethylene glycol)poly(L-lysine)-Succinate: Synthesis and Cytotoxic Properties," Bioconjugate Chem. 7: 144-149 (1996).(Issue No. 1).
Duncan, R., et al., "The role of polymer conjugates in the diagnosis and treatment of cancer," S.T.P. Pharma Sciences 6(4): 237-263 (1996). (Issue No. 4).
Duncan, Ruth, "Drug-polymer conjugates: potential for improved chemotherepy," Anti-Cancer Drugs #:175-210 (1992). (vol. 3).
Duncan, R., et al., "Anticancer agents coupled to N-(2-hydrozypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and purmycin conjugates in vitro," Br. J. Cancer 55:165-174 (1987).
Fiebig, H.H., et al., "GB-21, a novel platinum polymer with antitumor activity in human renal and mammary xenografts," Proceedings of the American Association for Cancer Research 37:297 Abstract No. 2021 (1996). (Apr. 24, 1996).
Filipova-Vorprsalova, Marie, et al., "Biodistribution of trans-1,2-diaminocyclohexane-trimellito-platinum(II) attached to macromolecular carriers I. Poly (hydroxethyl-D,L-asparagine) carrier," Journal of Controlled Release 17: 89-98 (1991).
Fujii, K., et al. "Control of Pharmacokinetics and Nephrotoxicity of cis-DDP by Alginate," Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 23: 639-640 (1996).
Han, Man Jung, et al., "Synthesis and Antitumor Activity of Polyanion-Pt-Complexes Containing Alicyclic Amines as Ligands," Journal of Bioactive and Compatible Polymers 9: 142-151 (1994). (Apr. 1994).
Johnsson, A., et al., "A topographic study on the distribution of cisplatin in xenografted tumors on nude mice," Anti-Cancer Drugs 7: 70-77 (1996).
Neuse, E.W., et al., "cis-Diaminedichloroplatinum(II) Complexes Reversibly Bound to Water-Soluble Polyaspartamide Carriers for Chemotherapeutic Applications. II: Platinum Coordination to Ethylenediamine Ligands Attached to Poly(ethylene oxide)-Grafted Carrier Polymers," Journal of Inorganic and Organometallic Polymers 5(3): 195-207 (1995).
Schechter, B., et al., "Soluble Polymers as Carriers of Cis-Platinum," Journal of Controlled Release 10: 75-87 (1989).
Seymour, L.W., et al., "Effect of molecular weight (M.sub.w) of N-(2-hydroxypropyl)mehtacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats," Journal of Biomedical Materials Research 21: 1341-1358 (1987).
Sohn, Youn Soo, et al., "Synthesis and antitumor activity of novel polysphosphazene-(diamine) platinum (II)," Int. J. Pharm 153:79-91 (1997).
Ranucci et al., "Poly(amidoamine)s with Potential as Drug Carriers: Degradation and Cellular Toxicity," J. Biomaterial Science, Polymer Ed., 2(4), 303-315 (1991); Chem. Abstr., 116, Abstr. No. 11092 (1992); only HCAPLUS version of Abstr. supplied.
Balazova, E. et al., "Antitumor Activity of Four Polymer Bound trans-1,2-diaminocyclohexaneplatinum (II)-4-carboxphtalate Complexes Tested in Different Model Systems," Neoplasma. 33:(06) 665-670 (1986).
Carraher, C.E. et al., "Polymeric Derivatives based on cis-Diamminedichloroplatinum (II) as Antineoplastic Agents," Biological Activities of Polymer. American Chemical Society. 221-231 (1982).
International Search Report for PCT Application No. PCT/US98/07659 (Oct. 30, 1998).
Ohya, Y. et al., "Synthesis and Cytotoxic Activity of Dextran-Immobilizing Platinum (II) Complex through Chelate-Type Coordination Bond," Pure Appl. Chem. A33(8) 1005-1016 (1996).
Neuse, E.W. et al., "Carrier Polymers for Cisplatin-type Anticancer Drug Models," Polymers for Advanced Technologies, John Wiley & Sons, Ltd. vol. 07, 867-872 (1996).
Duncan Ruth
Evagorou Evagoras G.
Ferruti Paolo
Access Pharmaceuticals Inc.
Crane L. Eric
Mohr Judy M.
LandOfFree
Polymer-platinum compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymer-platinum compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymer-platinum compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1325308